University research records
Shupyk National Healthcare University of Ukraine
5 imported, source-linked research records. Published in the last five years.
Published in the last five years
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Shupyk National Healthcare University of Ukraine are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
RC2.1 - ECE_2511 - Impact of SGLT2 inhibitors on telomere length in type 2 diabetes patients with and without chronic kidney disease
August 1, 2026 · 0 citations · Open access
Open original record →Effect of Treatment with Sodium-dependent Glucose Cotransporter Type 2 Inhibitors on the Levels of Oxidized Low-density Lipoproteins, Interleukin 17A, and Lipoprotein (a) in the Blood of Diabetic Patients who Have Recovered from COVID-19
September 24, 2025 · 0 citations · Open access
Open original record →CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
March 19, 2024 · 24 citations · Open access
Open original record →CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
March 16, 2023 · 11 citations · Open access
Open original record →OSTEOCALCIN ROLE IN THE REGULATION OF INSULIN SECRETION AND OSTEOTROPIC EFFECTS OF DIFFERENT CLASSES OF ANTI-DIABETIC DRUGS (LITERATURE REVIEW AND OWN RESEARCH)
May 8, 2022 · 1 citations · Open access
Open original record →